CoreWeave, Inc.
Filed Mar 3, 2025.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Mar 3, 2025
Contents
Cover page
Show cover page
S-11 d899798ds1.htm S-1
As filed with the U.S. Securities and Exchange Commission on March 3, 2025.
**Registration No. 333- **
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
**FORMS-1 **
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
(Exact name of registrant as specified in its charter)
| Delaware | 7372 | 82-3060021 |
|---|---|---|
| (State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification Number) |
290 W Mt. Pleasant Ave., Suite 4100
Livingston, NJ 07039
**(973)270-9737 **
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Michael Intrator
Chief Executive Officer
290 W Mt. Pleasant Ave., Suite 4100
Livingston, NJ 07039
**(973)270-9737 **
(Name, address, including zip code, and telephone number, including area code, of agent for service)
| Michael A. Brown Ran D. Ben-Tzur Jennifer J. Hitchcock Aman D. Singh Chance L. Goldberg Fenwick & West LLP902 Broadway, 18th FloorNew York, NY 10010 (212) 430-2600 | Kristen McVeety General Counsel Nisha Antony Deputy General Counsel CoreWeave, Inc. 290 W Mt. Pleasant Ave., Suite 4100Livingston, NJ 07039 (973) 270-9737 | Richard A. Kline Keith L. Halverstam Salvatore Vanchieri Erica D. Kassman Latham & Watkins LLP 1271 Avenue of the Americas New York, NY 10020 (212) 906-1675 |
|---|
Approximate date of commencement of proposed sale to the public:
As soon as practicable after the effective date of this registration statement.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended, or Securities Act, check the following box: ☐
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act of 1934, as amended.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
|---|---|---|---|
| Non-accelerated filer | ☒ | Smaller reporting company | ☐ |
| Emerging growth company | ☒ | ||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
The information in this preliminary prospectus is not complete and may be changed. We and the selling stockholders may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and we and the selling stockholders are not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED , 2025
PRELIMINARY PROSPECTUS
- Shares*
CoreWeave, Inc.
Class A Common Stock
This is the initial public offering of shares of Class A common stock of CoreWeave, Inc. We are offering shares of our Class A common stock and the selling stockholders identified in this prospectus are offering shares of our Class A common stock in this offering.
Prior to this offering, there has been no public market for our Class A common stock. We will not receive any proceeds from the sale of shares of Class A common stock by any of the selling stockholders. We expect that the initial public offering price per share of our Class A common stock will be between $ and $ per share.
We have applied to list our Class A common stock on The Nasdaq Stock Market LLC (“Nasdaq”) under the symbol “CRWV.” This offering is contingent upon final approval of our listing of our Class A common stock on Nasdaq.
We have two series of authorized common stock, Class A common stock and Class B common stock. The rights of the holders of our Class A common stock and Class B common stock are identical, except with respect to voting and conversion rights. Each share of our Class A common stock is entitled to one vote per share. Each share of our Class B common stock is entitled to ten votes per share and is convertible into one share of our Class A common stock. Immediately following the completion of this offering, and assuming no exercise of the underwriters’ option to purchase additional shares to cover over-allotments, if any, Michael Intrator, ourco-founder, Chief Executive Officer, President, and Chairman of our board of directors, will hold approximately % of the voting power of our outstanding capital stock, Brian Venturo, ourco-founder, Chief Strategy Officer and a member of our board of directors, will hold approximately % of the voting power of our outstanding capital stock, and Brannin McBee, ourco-founder and Chief Development Officer, will hold approximately % of the voting power of our outstanding capital stock. Mr. Intrator, Mr. Venturo, and Mr. McBee are our Co-Founders and collectively will hold approximately % of the voting power of our outstanding capital stock immediately following the completion of this offering. As a result, following this offering, our Co-Founders, together, may have significant influence over the outcome of matters submitted to our stockholders for approval, including the election of our directors and the approval of any change of control transaction.
We will be treated as an “emerging growth company” as defined under the federal securities laws for certain purposes until we complete this offering. As such, in this prospectus we have taken advantage of certain reduced disclosure obligations that apply to emerging growth companies.
Investing in our Class A common stock involves risks. See the section titled “Risk Factors” beginning on page 26 to read about factors you should consider before buying shares of our Class A common stock.
Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.
| Per Share | Total | |||
| Initial public offering price | $ | $ | ||
|---|---|---|---|---|
| Underwriting discounts and commissions(1) | $ | $ | ||
| Proceeds, before expenses, to us | $ | $ | ||
| Proceeds, before expenses, to Selling Stockholders | $ | $ |
| (1) | See the section titled “Underwriting (Conflicts of Interest)” for a description of the compensation payable to the underwriters. |
The underwriters have the option for a period of 30 days from the date of this prospectus to purchase up to an additional shares of our Class A common stock from us to cover over-allotments, if any, at the initial public offering price less underwriting discounts and commissions.
The underwriters expect to deliver the shares of our Class A common stock to purchasers on or about , 2025.
| MORGAN STANLEY | J.P. MORGAN | GOLDMAN SACHS & CO. LLC |
|---|
| BARCLAYS | CITIGROUP | MUFG | ||
|---|---|---|---|---|
| DEUTSCHE BANK SECURITIES | JEFFERIES | MIZUHO | WELLS FARGO SECURITIES | BOFA SECURITIES |
| GUGGENHEIM SECURITIES | NEEDHAM & COMPANY | GALAXY DIGITAL |
|---|
Prospectus dated , 2025
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.